^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

PDGFRA exon 18 mutation

i
Other names: Platelet Derived Growth Factor Receptor Alpha, Platelet-Derived Growth Factor Receptor Alpha Polypeptide, Alpha-Type Platelet-Derived Growth Factor Receptor, CD140 Antigen-Like Family Member A, CD140a Antigen, PDGF-R-Alpha, PDGFR-2, PDGFR2, Alpha Platelet-Derived Growth Factor Receptor, Platelet-Derived Growth Factor Alpha Receptor, PDGFR-Alpha, RHEPDGFRA, CD140A
Entrez ID:
Phase 1
IDRx, Inc.
Recruiting
Last update posted :
04/09/2024
Initiation :
08/01/2022
Primary completion :
04/24/2026
Completion :
09/13/2026
PDGFRA
|
KIT mutation • PDGFRA mutation • PDGFRA exon 18 mutation
|
sunitinib • IDRX-42
Phase N/A
Blueprint Medicines Corporation
Approved for marketing
Last update posted :
07/27/2020
PDGFRA
|
PDGFRA D842V • PDGFRA mutation • PDGFRA exon 18 mutation
|
Ayvakit (avapritinib)
Phase N/A
Peking University Cancer Hospital & Institute
Unknown status
Last update posted :
05/18/2016
Initiation :
05/01/2016
Primary completion :
10/01/2017
Completion :
05/01/2018
KIT • PDGFRA • ANO1
|
KIT exon 11 mutation • PDGFRA mutation • KIT wild-type • PDGFRA exon 18 mutation • PDGFR wild-type
|
dasatinib